PERI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. PERI is deeply oversold (RSI19) and sitting near support (8.83), which can produce a short-term bounce, but the primary trend remains bearish (SMA200>SMA20>SMA5 and MACD histogram negative and worsening). With no Intellectia buy signals today and deteriorating profitability in the latest quarter, the risk of another leg down remains material. For an impatient buyer, the setup is not favorable enough to justify an immediate entry.
Trend/structure: Bearish trend intact with stacked bearish moving averages (SMA_200 > SMA_20 > SMA_5), indicating sustained downside momentum. Momentum: MACD histogram -0.0445 and negatively expanding -> bearish momentum is strengthening, not stabilizing yet. Oversold: RSI_6 at ~19 is extremely oversold, increasing odds of a reflex bounce, but oversold can persist in downtrends. Levels: Pre-market ~8.97 is below the pivot (9.203). Immediate support is S1 ~8.825 (then S2 ~8.591). Resistance levels are ~9.58 (R1) and ~9.82 (R2). A credible “buy-now” would look better after reclaiming the pivot (9.203) or showing momentum stabilization.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
can trigger short-term mean reversion rallies, especially if broader market stabilizes.
Primary trend is still bearish: moving averages and MACD show continuing downside momentum, so catching a falling knife risk remains high.
Profitability deteriorated in the latest quarter: net income turned worse (loss) and EPS declined sharply, with gross margin also down.
No supportive near-term news flow in the past week; absent a catalyst, bounces can fail quickly.
Next earnings (2026-02-18 pre-market) is the next major event; until then, price may continue to be driven by technicals and sentiment.
Latest quarter (2025/Q3): Revenue grew to $110.46M (+8.09% YoY), signaling top-line improvement. However, profitability weakened materially: Net income was -$4.08M (down -292.95% YoY), EPS was -0.10 (down -350% YoY), and gross margin fell to 29.18% (-8.30% YoY). Overall: growth returned, but margins/earnings quality deteriorated, which limits conviction for an immediate buy.
Recent Street trend (Nov 2025): constructive. Lake Street raised PT to $15 (from $14) and reiterated Buy; Roth raised PT to $14.50 (from $14) and reiterated Buy, framing Q3 as an inflection back to YoY growth and citing buyback support. Wall Street pros: improving revenue trajectory, potential undervaluation, and capital return support. Cons: profitability and margins are currently moving the wrong direction and the chart is still in a downtrend.
Influential/political trading check: Hedge funds and insiders are neutral with no significant recent trends, and no recent Congress trading data is available.
